These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 4982122)
21. Evaluations of a patient isolator system. I. Evaluations of subsystems and procedures for sterilization and concurrent sanitation. Shadomy S; Ginsberg MK; Laconte M; Zeiger E Arch Environ Health; 1965 Aug; 11(2):183-90. PubMed ID: 4953518 [No Abstract] [Full Text] [Related]
22. [Prevention of infection in patients with agranulocytosis through isolation and whole-body decontamination]. Fopp M; Gasser A; Eigenmann B; Jungi WF; Meuret G; Senn HJ Schweiz Med Wochenschr; 1975 Aug; 105(35):1123-5. PubMed ID: 808849 [TBL] [Abstract][Full Text] [Related]
23. [Low-green environment for the overcoming of granulocytopenic stages in leukemia therapy]. Wendt F; Grüning B; Lenz B; Brittinger G; Linzenmeier G Verh Dtsch Ges Inn Med; 1969; 75():916-20. PubMed ID: 4993911 [No Abstract] [Full Text] [Related]
24. Protective isolation in a burns unit: the use of plastic isolators and air curtains. Lowbury EJ; Babb JR; Ford PM J Hyg (Lond); 1971 Dec; 69(4):529-46. PubMed ID: 5002642 [TBL] [Abstract][Full Text] [Related]
25. Efficacy of the Shinki bioclean room for preventing infection in neutropenic patients. Shinjo K; Takeshita A; Yanagi M; Yokota K; Hirano K; Suzuki M; Ohnishi K; Ohno R J Adv Nurs; 2002 Feb; 37(3):227-33. PubMed ID: 11851792 [TBL] [Abstract][Full Text] [Related]
26. Infection prevention in patients with cancer: microbiological evaluation of portable laminar air flow isolation, topical chlorhexidine, and oral non-absorbable antibiotics. Spiers AS; Dias SF; Lopez JA J Hyg (Lond); 1980 Jun; 84(3):457-65. PubMed ID: 7052225 [TBL] [Abstract][Full Text] [Related]
27. Protected environment units for the cancer patient. Bodey GP; Watson P; Cooper C; Freireich EJ CA Cancer J Clin; 1971; 21(4):215-9. PubMed ID: 4998235 [No Abstract] [Full Text] [Related]
28. Microbiological monitoring of protected environment units. Effects of antibiotic prophylaxis and type of unit. Bodey GP; Rosenbaum B Eur J Cancer (1965); 1980 Jan; 16(1):67-75. PubMed ID: 7358080 [No Abstract] [Full Text] [Related]
29. Infection prevention for patients with acute leukemia using laminar air flow rooms. Masaoka T Tokai J Exp Clin Med; 1986; 11 Suppl():9-14. PubMed ID: 2837838 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of acute myeloblastic leukemias under sterile conditions using a laminar down-flow system for the pervention of infection in comparison with single-room treatment]. Beyer JH; Schmidt CG; Linzenmeier G; Hantschke D Verh Dtsch Ges Inn Med; 1975; 81():1119-21. PubMed ID: 1065152 [No Abstract] [Full Text] [Related]
32. [Treatment of acute leukaemia and medullary inhibition in aseptic environment (author's transl)]. Bláha M; Vanásek J; Mĕrka V; Erichleb M; Splino M; Siroký O; Mazák J; Hrncír Z; Malý J Cas Lek Cesk; 1978 Jun; 117(22-23):698-701. PubMed ID: 98234 [No Abstract] [Full Text] [Related]
33. [Bacterial flora in patients with acute leukemia during a specific treatment]. Dronova OM; Smolianskaya AZ; Khvatova NV; Lorie IuI Probl Gematol Pereliv Krovi; 1971 Dec; 16(12):27-9. PubMed ID: 4945960 [No Abstract] [Full Text] [Related]
34. Nosocomial infections and the urologist. Evans AT J Urol; 1974 Jun; 111(6):813-6. PubMed ID: 4598375 [No Abstract] [Full Text] [Related]
35. Studies of the effectiveness of an isolation ward. Williams RE; Harding L J Hyg (Lond); 1969 Dec; 67(4):649-58. PubMed ID: 5261209 [No Abstract] [Full Text] [Related]
36. Antibiotic prophylaxis for temporary transvenous pacemakers. Patton RD; Kenamore B; Stein E N Engl J Med; 1969 Nov; 281(20):1106-8. PubMed ID: 4980935 [No Abstract] [Full Text] [Related]
37. Simple and microbiologically safe portable transport unit for patients requiring protected isolation. Talbot TL; Pizzo PA J Clin Microbiol; 1980 Mar; 11(3):234-7. PubMed ID: 6769945 [TBL] [Abstract][Full Text] [Related]
38. Hypersplenism due to disseminated candidiasis in a patient with acute leukemia. Bodey GP; DeJongh D; Isassi A; Freireich EJ Cancer; 1969 Aug; 24(2):417-20. PubMed ID: 5256261 [No Abstract] [Full Text] [Related]
39. Application of simplified bioclean apparatuses for treatment of acute leukemia. Hasegawa H; Horiuchi A Jpn J Clin Oncol; 1983; 13 Suppl 1():133-42. PubMed ID: 6834656 [TBL] [Abstract][Full Text] [Related]
40. An isolator system for the maintenance of aseptic environments. Trexler PC Lancet; 1973 Jan; 1(7794):91-3. PubMed ID: 4118663 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]